Life-threatening Vasospastic Angina Induced by Carteolol Eye Drops

Intern Med. 2023 Sep 1;62(17):2513-2516. doi: 10.2169/internalmedicine.0495-22. Epub 2022 Dec 7.

Abstract

Vasospastic angina (VSA) can be worsened by oral nonselective beta-blockers. Ophthalmic carteolol eye drops are nonselective beta-blockers and effective against glaucoma and ocular hypertension. Systemic effects of ophthalmic beta-blockers on VSA have not yet been reported. We herein report a case of VSA that developed after a patient started carteolol eye drops for ocular hypertension. Even though benidipine, a calcium channel blocker, was started, a VSA attack with incessant non-sustained ventricular tachycardia occurred. Once the carteolol eyedrops were discontinued, the VSA resolved. This case demonstrates that carteolol eye drops can induce life-threatening VSA.

Keywords: carteolol; ophthalmic beta-blocker; vasospastic angina.

Publication types

  • Case Reports

MeSH terms

  • Adrenergic beta-Antagonists / adverse effects
  • Angina Pectoris, Variant*
  • Carteolol* / adverse effects
  • Coronary Vasospasm* / chemically induced
  • Coronary Vasospasm* / drug therapy
  • Glaucoma*
  • Humans
  • Ocular Hypertension* / chemically induced
  • Ocular Hypertension* / drug therapy
  • Ophthalmic Solutions / adverse effects

Substances

  • Carteolol
  • Ophthalmic Solutions
  • Adrenergic beta-Antagonists